Protokinetix to Open Washington, D.C. Office

To accommodate growth and to take advantage of current opportunities, ProtoKinetix, Inc. (OTCBB:PKTX) is opening an office in Washington, D.C. In recent weeks, the company has expanded its management and business development team to include Dr. Edward D. Martin, M.D. of Martin, Blanck and Associates, Donald J. Weber of Logistics Health, Inc. and Randy Anderson as Vice President of Government Affairs. The new office will serve as a central hub to access the multiple government and non-government health related agencies. The Washington, D.C. office will enable our business development team to accelerate strategic relationships required to optimize the value of the many applications of AAGP™.

Commenting on this new development, ProtoKinetix’ CEO and President Ross L. Senior said, “This is a significant step forward for the company.” Mr. Senior stated that “the decision to open a Washington, D.C. office is in anticipation of the favorable conclusion to ongoing dialogue with prospective partners and negotiations with commercial entities.” He added that “promising results from a variety of recent tests and preliminary trials using ProtoKinetix’ AAGP™ in cryopreservation of multiple cells lines helped the Board reach its decision.”

Randy Anderson will head up this new venture for PKTX and enthusiastically endorses the move as giving a clear direction of where the company is headed. Anderson goes on to say, “We are pleased with recent progress and excited about the short term as well as the extended outlook of the company. I look forward to reporting further developments in the days to come.”

About ProtoKinetix

ProtoKinetix, Inc. is a biotechnology company that has developed and patented a family of synthetic anti-aging glycopeptides (AAGP™) for medicine and the biotechnology and cosmetic industries. PKTX is currently in dialogue with major corporations and institutions who have contacted the company about the broad range of applications for AAGP™ products.

For more detailed information, please visit our website at: www.protokinetix.com

The Private Securities Litigation Reform Act of 1995 provides a “safe harbor” for forward-looking statements. Some information included in this press release contains statements that are forward-looking. Such forward-looking information involves significant risks and uncertainties that could affect anticipated results in the future and, accordingly, these results may differ materially from those expressed in any forward-looking statements made by or on behalf of the Company. For a description of additional risks and uncertainties, please refer to the Company’s filings with the Securities and Exchange Commission.

Ross L. Senior, President and CEO

ProtoKinetix Inc.
Investor Contact
Blair Henderson, 604-687-9887